Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization

Highlights ► Global Vaccine Safety Blueprint Strategy developed in 2011. ► Strategy is based on landscape analysis of vaccine safety stakeholders and systems. ► Strategy aims at minimal and enhanced country capacity and global support network. ► Global Vaccine Safety Initiative launched 2012, suppor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2013-04, Vol.31, p.B108-B114
Hauptverfasser:	Amarasinghe, Ananda, Black, Steve, Bonhoeffer, Jan, Carvalho, Sandra M. Deotti, Dodoo, Alexander, Eskola, Juhani, Larson, Heidi, Shin, Sunheang, Olsson, Sten, Balakrishnan, Madhava Ram, Bellah, Ahmed, Lambach, Philipp, Maure, Christine, Wood, David, Zuber, Patrick, Akanmori, Bartholomew, Bravo, Pamela, Pombo, María, Langar, Houda, Pfeifer, Dina, Guichard, Stéphane, Diorditsa, Sergey, Hossain, Md. Shafiqul, Sato, Yoshikuni
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Drug Reaction Reporting Systems - organization & administration Allergy and Immunology Blueprint Developed Countries Developing Countries disaster recovery Global Vaccine Safety Global Vaccine Safety Initiative GVSI Humans Immunization Immunization - adverse effects Immunization Programs Immunization safety International Cooperation landscapes monitoring Pharmacovigilance Post marketing surveillance Safety stakeholders Vaccine Safety vaccines Vaccines - adverse effects World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights ► Global Vaccine Safety Blueprint Strategy developed in 2011. ► Strategy is based on landscape analysis of vaccine safety stakeholders and systems. ► Strategy aims at minimal and enhanced country capacity and global support network. ► Global Vaccine Safety Initiative launched 2012, supports implementation of Strategy. ► Decade of Vaccines is opportunity to raise awareness for Blueprint implementation.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2012.10.119